NK cell subsets and their role in allergy

Expert Opinion on Biological Therapy

Volumn 11, Issue 7, 2011, Pages 833-841

  Deniz, Gunnur ^a   Akdis, Mubeccel ^b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b SWISS INSTITUTE OF ALLERGY AND ASTHMA RESEARCH SIAF   (Switzerland)

Author keywords

allergy; cytokines; cytotoxicity; NK cell subsets; NK cells

Indexed keywords

CELL RECEPTOR; CYTOKINE; IMMUNOGLOBULIN; INTERLEUKIN 17; INTERLEUKIN 22;

ALLERGY; B LYMPHOCYTE; BONE MARROW TRANSPLANTATION; CELL ACTIVATION; CELL FUNCTION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOTOXICITY; DENDRITIC CELL; HUMAN; IMMUNE RESPONSE; NATURAL KILLER 1 CELL; NATURAL KILLER 2 CELL; NATURAL KILLER 22 CELL; NATURAL KILLER CELL; NONHUMAN; PHENOTYPE; REVIEW;

ADAPTIVE IMMUNITY; ANIMALS; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; HUMANS; HYPERSENSITIVITY; IMMUNITY, INNATE; KILLER CELLS, NATURAL; LYMPHOCYTE SUBSETS; PHENOTYPE; RECEPTORS, NATURAL KILLER CELL; SIGNAL TRANSDUCTION;

EID: 79958076098     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712598.2011.572549     Document Type: Review

References (75)

1. Hamerman JA, Ogasawara K, Lanier LL. NK cells in innate immunity. Curr Opin Immunol 2005;17:29-35 (Pubitemid 40094010)
2. Herberman RB. Natural killer cells. Annu Rev Med 1986;37:347-52
3. Larosa DF, Orange JS. Lymphocytes. J Allergy Clin Immunol 2008;121(Suppl 2):S364-9; quiz S412
4. Das A, Long EO. Lytic granule polarization, rather than degranulation, is the preferred target of inhibitory receptors in NK cells. J Immunol 2010;185:4698-704
5. Screpanti V, Wallin RP, Grandien A, Ljunggren HG. Impact of FASL-induced apoptosis in the elimination of tumor cells by NK cells. Mol Immunol 2005;42:495-9 (Pubitemid 39655960)
6. Takeda K, Hayakawa Y, Smyth MJ, et al. Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells. Nat Med 2001;7:94-100 (Pubitemid 32095647)
7. Wallin RP, Screpanti V, Michaelsson J, et al. Regulation of perforin-independent NK cell-mediated cytotoxicity. Eur J Immunol 2003;33:2727-35 (Pubitemid 37337138)
8. Colonna M. NK cells: new issues and challenges. Eur J Immunol 2008;38:2927-9
9. Caligiuri MA. Human natural killer cells. Blood 2008;112:461-9
10. Zwirner NW, Domaica CI. Cytokine regulation of natural killer cell effector functions. Biofactors 2010;36:274-88
11. Shimizu K, Fujii S. DC therapy induces long-term NK reactivity to tumors via host DC. Eur J Immunol 2009;39:457-68
12. Loza MJ, Perussia B. Final steps of natural killer cell maturation: a model for type 1-type 2 differentiation? Nat Immunol 2001;2:917-24 (Pubitemid 32976163)
13. Trinchieri G. Biology of natural killer cells. Adv Immunol 1989;47:187-376 (Pubitemid 20010960)
14. Orange JS, Ballas ZK. Natural killer cells in human health and disease. Clin Immunol 2006;118:1-10 (Pubitemid 43012040)
15. Hanna J, Bechtel P, Zhai Y, et al. Novel insights on human NK cells' immunological modalities revealed by gene expression profiling. J Immunol 2004;173:6547-63 (Pubitemid 39541038)
16. Lanier LL. NK cell receptors. Annu Rev Immunol 1998;16:359-93 (Pubitemid 28183369)
17. Moretta A, Bottino C, Vitale M, et al. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol 2001;19:197-223 (Pubitemid 32368034)
18. Schleinitz N, March ME, Long EO. Recruitment of activation receptors at inhibitory NK cell immune synapses. PLoS One 2008;3(9):e3278
19. Gardiner CM. Killer cell immunoglobulin-like receptors on NK cells: the how, where and why. Int J Immunogenet 2008;35:1-8
20. Mandelboim O, Porgador A. NKp46. Int J Biochem Cell Biol 2001;33:1147-50 (Pubitemid 32972199)
21. Sivori S, Vitale M, Morelli L, et al. p46, a novel natural killer cell-specific surface molecule that mediates cell activation. J Exp Med 1997;186:1129-36 (Pubitemid 27441156)
22. Vitale M, Bottino C, Sivori S, et al. NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis. J Exp Med 1998;187:2065-72 (Pubitemid 28285576)
23. Shereck E, Satwani P, Morris E, Cairo MS. Human natural killer cells in health and disease. Pediatr Blood Cancer 2007;49:615-23 (Pubitemid 350194423)
24. Arnon TI, Achdout H, Levi O, et al. Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus. Nat Immunol 2005;6:515-23 (Pubitemid 41716765)
25. Bryceson YT, Ljunggren HG, Long EO. Minimal requirement for induction of natural cytotoxicity and intersection of activation signals by inhibitory receptors. Blood 2009;114:2657-66
26. Liu D, Bryceson YT, Meckel T, et al. Integrin-dependent organization and bidirectional vesicular traffic at cytotoxic immune synapses. Immunity 2009;31:99-109
27. Walzer T, Chiossone L, Chaix J, et al. Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor. Nat Immunol 2007;8:1337-44 (Pubitemid 350131171)
28. Zitvogel L. Dendritic and natural killer cells cooperate in the control/switch of innate immunity. J Exp Med 2002;195:F9-14 (Pubitemid 34461485)
29. Moretta A. Natural killer cells and dendritic cells: rendezvous in abused tissues. Nat Rev Immunol 2002;2:957-64 (Pubitemid 37323216)
30. Moretta L, Ferlazzo G, Bottino C, et al. Effector and regulatory events during natural killer-dendritic cell interactions. Immunol Rev 2006;214:219-28 (Pubitemid 44707913)
31. Zanoni I, Granucci F, Foti M, Ricciardi-Castagnoli P. Self-tolerance, dendritic cell (DC)-mediated activation and tissue distribution of natural killer (NK) cells. Immunol Lett 2007;110:6-17 (Pubitemid 46678227)
32. Chauveau A, Aucher A, Eissmann P, et al. Membrane nanotubes facilitate long-distance interactions between natural killer cells and target cells. Proc Natl Acad Sci USA 2010;107:5545-50
33. Farag SS, Caligiuri MA. Human natural killer cell development and biology. Blood Rev 2006;20:123-37 (Pubitemid 43786166)
34. Poli A, Michel T, Theresine M, et al. CD56bright natural killer (NK) cells: an important NK cell subset. Immunology 2009;126:458-65
35. Jonges LE, Albertsson P, van Vlierberghe RL, et al. The phenotypic heterogeneity of human natural killer cells: presence of at least 48 different subsets in the peripheral blood. Scand J Immunol 2001;53:103-10 (Pubitemid 32154527)
36. Cooper MA, Fehniger TA, Caligiuri MA. The biology of human natural killer-cell subsets. Trends Immunol 2001;22:633-40 (Pubitemid 33043908)
37. Hayakawa Y, Smyth MJ. CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity. J Immunol 2006;176:1517-24 (Pubitemid 43134295)
38. Silva A, Andrews DM, Brooks AG, et al. Application of CD27 as a marker for distinguishing human NK cell subsets. Int Immunol 2008;20:625-30 (Pubitemid 351426054)
39. Vossen MT, Matmati M, Hertoghs KM, et al. CD27 defines phenotypically and functionally different human NK cell subsets. J Immunol 2008;180:3739-45
40. Cooper MA, Fehniger TA, Turner SC, et al. Human natural killer cells: a unique innate immunoregulatory role for the CD56bright subset. Blood 2001;97:3146-51
41. Wei H, Zhang J, Xiao W, et al. Involvement of human natural killer cells in asthma pathogenesis: natural killer 2 cells in type 2 cytokine predominance. J Allergy Clin Immunol 2005;115:841-7 (Pubitemid 40460863)
42. Zhang J, Sun R, Liu J, et al. Reverse of NK cytolysis resistance of type 2 cytokine predominant-human tumor cells. Int Immunopharmacol 2006;6:1176-80 (Pubitemid 44250758)
43. Wei H, Zheng X, Lou D, et al. Tumor-induced suppression of interferon-gamma production and enhancement of interleukin-10 production by natural killer (NK) cells: paralleled to CD4+ T cells. Mol Immunol 2005;42:1023-31
44. Peritt D, Robertson S, Gri G, et al. Differentiation of human NK cells into NK1 and NK2 subsets. J Immunol 1998;161:5821-4 (Pubitemid 28535946)
45. Deniz G, Akdis M, Aktas E, et al. Human NK1 and NK2 subsets determined by purification of IFN-gamma-secreting and IFN-gamma-nonsecreting NK cells. Eur J Immunol 2002;32:879-84 (Pubitemid 34257565)
46. Papewalis C, Jacobs B, Wuttke M, et al. IFN-alpha skews monocytes into CD56 +-expressing dendritic cells with potent functional activities in vitro and in vivo. J Immunol 2008;180:1462-70
47. Yu G, Xu X, Vu MD, et al. NK cells promote transplant tolerance by killing donor antigen-presenting cells. J Exp Med 2006;203:1851-8 (Pubitemid 44188459)
48. Saito S, Nakashima A, Myojo-Higuma S, Shiozaki A. The balance between cytotoxic NK cells and regulatory NK cells in human pregnancy. J Reprod Immunol 2008;77:14-22
49. Deniz G, Erten G, Kucuksezer UC, et al. Regulatory NK cells suppress antigen-specific T cell responses. J Immunol 2008;180:850-7
50. Colonna M. Interleukin-22-producing natural killer cells and lymphoid tissue inducer-like cells in mucosal immunity. Immunity 2009;31:15-23
51. Luci C, Reynders A, Ivanov II, et al. Influence of the transcription factor RORgammat on the development of NKp46+ cell populations in gut and skin. Nat Immunol 2009;10:75-82
52. Cella M, Fuchs A, Vermi W, et al. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 2009;457:722-5
53. Zenewicz LA, Flavell RA. IL-22 and inflammation: leukin' through a glass onion. Eur J Immunol 2008;38:3265-8
54. Akdis CA. Allergy and hypersensitivity: mechanisms of allergic disease. Curr Opin Immunol 2006;18:718-26 (Pubitemid 44635184)
55. Akdis M. The cellular orchestra in skin allergy; are differences to lung and nose relevant? Curr Opin Allergy Clin Immunol 2010;10:443-51
56. Canonica GW. Introduction to nasal and pulmonary allergy cascade. Allergy 2002;57(Suppl 75):8-12 (Pubitemid 36140450)
57. Herrick CA, Bottomly K. To respond or not to respond: T cells in allergic asthma. Nat Rev Immunol 2003;3:405-12 (Pubitemid 37323200)
58. Akdis M, Akdis CA, Weigl L, et al. Skin-homing, CLA+ memory T cells are activated in atopic dermatitis and regulate IgE by an IL-13-dominated cytokine pattern: IgG4 counter-regulation by CLA- memory T cells. J Immunol 1997;159:4611-19 (Pubitemid 127470624)
59. Akdis M, Simon HU, Weigl L, et al. Skin homing (cutaneous lymphocyte-associated antigen-positive) CD8+ T cells respond to superantigen and contribute to eosinophilia and IgE production in atopic dermatitis. J Immunol 1999;163:466-75 (Pubitemid 29295875)
60. Aktas E, Akdis M, Bilgic S, et al. Different natural killer (NK) receptor expression and immunoglobulin E (IgE) regulation by NK1 and NK2 cells. Clin Exp Immunol 2005;140:301-9
61. von Bubnoff D, Andres E, Hentges F, et al. Natural killer cells in atopic and autoimmune diseases of the skin. J Allergy Clin Immunol 2010;125:60-8
62. Wehrmann W, Reinhold U, Kukel S, et al. Selective alterations in natural killer cell subsets in patients with atopic dermatitis. Int Arch Allergy Appl Immunol 1990;92:318-22
63. Carbone T, Nasorri F, Pennino D, et al. CD56highCD16-CD62L- NK cells accumulate in allergic contact dermatitis and contribute to the expression of allergic responses. J Immunol 2010;184:1102-10
64. Paust S, Gill HS, Wang BZ, et al. Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigenspecific memory of haptens and viruses. Nat Immunol 2010;11:1127-35
65. Mesdaghi M, Vodjgani M, Salehi E, et al. Natural killer cells in allergic rhinitis patients and nonatopic controls. Int Arch Allergy Immunol 2010;153:234-8
66. Kawakami Y, Tomimori Y, Yumoto K, et al. Inhibition of NK cell activity by IL-17 allows vaccinia virus to induce severe skin lesions in a mouse model of eczema vaccinatum. J Exp Med 2009;206:1219-25
67. Han X, Fan Y, Wang S, et al. NK cells contribute to intracellular bacterial infection-mediated inhibition of allergic responses. J Immunol 2008;180:4621-8
68. Scordamaglia F, Balsamo M, Scordamaglia A, et al. Perturbations of natural killer cell regulatory functions in respiratory allergic diseases. J Allergy Clin Immunol 2008;121:479-85 (Pubitemid 351222648)
69. Cooper MA, Fehniger TA, Fuchs A, et al. NK cell and DC interactions. Trends Immunol 2004;25:47-52 (Pubitemid 38032807)
70. Vitale M, Della Chiesa M, Carlomagno S, et al. NK-dependent DC maturation is mediated by TNFalpha and IFNgamma released upon engagement of the NKp30 triggering receptor. Blood 2005;106:566-71 (Pubitemid 40981252)
71. Weaver CT, Hatton RD, Mangan PR, et al. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol 2007;25:821-52 (Pubitemid 46697925)
72. Eyerich K, Foerster S, Rombold S, et al. Patients with chronic mucocutaneous candidiasis exhibit reduced production of Th17-associated cytokines IL-17 and IL-22. J Invest Dermatol 2008;128:2640-5
73. Nograles KE, Zaba LC, Shemer A, et al. IL-22-producing "T22" T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells. J Allergy Clin Immunol 2009;123:1244-52 e2
74. Vivier E, Spits H, Cupedo T. Interleukin-22-producing innate immune cells: new players in mucosal immunity and tissue repair? Nat Rev Immunol 2009;9:229-34
75. Cella M, Otero K, Colonna M. Expansion of human NK-22 cells with IL-7, IL-2, and IL-1beta reveals intrinsic functional plasticity. Proc Natl Acad Sci USA 2010;107:10961-6